An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S129-S137

  Tsuda, Yoshimi ^a,c   Hoenen, Thomas ^b   Banadyga, Logan ^a   Weisend, Carla ^a   Ricklefs, Stacy M ^a   Porcella, Stephen F ^a   Ebihara, Hideki ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Laboratory of Molecular Virology   (United States)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ebola virus; mutation; reverse genetics system; RNA editing site

Indexed keywords

RNA DIRECTED RNA POLYMERASE; GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EBOLAVIRUS; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; RNA EDITING; RNA REPLICATION; VERO CELL LINE; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; EBOLA HEMORRHAGIC FEVER; GENETICS; HEK293 CELL LINE; MUTATION; PROCEDURES; TUMOR CELL LINE; VIROLOGY;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; EBOLAVIRUS; GENOME, VIRAL; GENOMIC INSTABILITY; GLYCOPROTEINS; HEK293 CELLS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MUTATION; REVERSE GENETICS; VERO CELLS; VIRUS REPLICATION;

EID: 84932616092     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu681     Document Type: Article

References (25)

1. Feldmann H, Sanchez A, Geisbert T. Filoviridae: Marburg and Ebola viruses. In: Knipe D, Howley P, eds. Fields virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2013:923-56.
2. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377:849-62.
3. Pourrut X, Kumulungui B, Wittmann T, et al. The natural history of Ebola virus in Africa. Microbes Infect 2005; 7:1005-14.
4. Volchkov VE, Volchkova VA, Muhlberger E, et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001; 291:1965-9.
5. Neumann G, Feldmann H,Watanabe S, Lukashevich I, Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 2002; 76:406-10.
6. Conzelmann KK. Reverse genetics of mononegavirales. Curr Top Microbiol Immunol 2004; 283:1-41.
7. Ebihara H, Groseth A, Neumann G, Kawaoka Y, Feldmann H. The role of reverse genetics systems in studying viral hemorrhagic fevers. Thromb Haemost 2005; 94:240-53.
8. Hoenen T, Groseth A, de Kok-Mercado F, Kuhn JH, Wahl-Jensen V. Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res 2011; 91:195-208.
9. Ebihara H, Takada A, Kobasa D, et al. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog 2006; 2:e73.
10. Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE. Role of VP30 phosphorylation in the Ebola virus replication cycle. J Infect Dis 2011; 204(suppl 3):S934-40.
11. Hoenen T, Shabman RS, Groseth A, et al. Inclusion bodies are a site of ebolavirus replication. J Virol 2012; 86:11779-88.
12. Volchkov VE, Becker S, Volchkova VA, et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995; 214:421-30.
13. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 1996; 93:3602-7.
14. Mehedi M, Falzarano D, Seebach J, et al. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol 2011; 85:5406-14.
15. Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis 2011; 204(suppl 3):S941-6.
16. Kugelman JR, Lee MS, Rossi CA, et al. Ebola virus genome plasticity as a marker of its passaging history: A comparison of in vitro passaging to non-human primate infection. PLoS One 2012; 7:e50316.
17. Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 2003; 47:613-7.
18. Yanai H, Hayashi Y, Watanabe Y, et al. Development of a novel Borna disease virus reverse genetics system using RNA polymerase II promoter and SV40 nuclear import signal. Microb Infect 2006; 8:1522-9.
19. Ebihara H, Yoshimatsu K, Ogino M, et al. Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. J Virol 2000; 74:9245-55.
20. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S177-87.
21. Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol 1999; 73: 2333-42.
22. Hoenen T, Jung S, Herwig A, Groseth A, Becker S. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 2010; 403:56-66.
23. Mehedi M, Hoenen T, Robertson S, et al. Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure. PLoS Pathog 2013; 9:e1003677.
24. Wahl-Jensen V, Kurz SK, Hazelton PR, et al. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol 2005; 79:2413-9.
25. Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melen K, Julkunen I. Impaired antiviral response in human hepatoma cells. Virology 1999; 263:364-75.